A Case of Hair Change and Acneiform Eruption Induced by ZD1839 (Iressa)
January 2004
in “
Linchuang pifuke zazhi
”
Studysummary In a reported case, the use of ZD1839 (Iressa), an EGFR tyrosine kinase inhibitor, resulted in hair changes and acneiform eruptions as cutaneous side effects.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
ZD1839 (Iressa$^{(R)}$), an anticancer agent that inhibits EGFR tyrosine kinase, was reported to cause cutaneous side effects such as acneiform eruptions, dry skin, and hair abnormalities. These side effects were linked to the disruption of normal epidermal and hair follicle processes. The document detailed a specific case where a patient experienced hair changes and acneiform eruptions due to the use of ZD1839.
